drugset / Trial / NCT00206700
Open-label Trial of Leukine in Active Crohn's Disease
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to establish a safety profile sargramostim administered in 8 week cycles to adult patients with active Crohn's disease.
Timeline
- Start
- 2003-02
- Primary completion
- 2006-12
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | sargramostim | Protein / enzyme biologic | — | — |